Get addiction help now: (858) 838-4343

get help now

Get addiction help now: (858) 838-4343

get help now

CERTIFIED MEDICATION ASSISTED TREATMENT (MAT) ADVOCATE (CMA)-1

Time to read: 2 min

The Basic Advocacy Training Session

The training for certification includes a variety of topics to give advocates a well-grounded understanding of MAT, research, regulations and laws that protect MAT patients and programs.

  1. Medication Assisted Treatment  Basic clinical information about methadone and buprenorphine treatment.

  2. Regulations and Accreditation The federal regulations will be explained:  What they are and how they relate to the state regulations? Accreditation and what an accreditation survey is, how it is done, and how advocates can be involved.

  3. The Basics of Advocacy The different kinds of advocacy from “Hands On” Individual Advocacy (handling a grievavce), Networking, Systems Advocacy, Working with Policy Makers and Politicians.

  4. Stigma and Prejudice Patients themselves are often the greatest spreaders of stigma through ignorance and myths. Stigma will only end when society is educated about the effectiveness and benefits of MAT from the bottom up. We need to start with patients who can become ambassadors for MAT but this will be most effective with the support of policy makers and regulating agencies. The Media also spreads misinformation and stigma about MAT. Advocates need to have basic skills to work with the Media and write an Editorial, Letter to the Editor LTE and a Press Release.

  5. Advocate Certification What is certification and how it will professionalize those committed to MAT advocacy.  The Advocates Code of Ethics, the Goals of MAT Advocacy, and Advocate Certification.

Similar Posts

Index

ByAdmin
Admin 07/03/2022

Education Series 1 Methadone Maintenance and Patient Self Advocacy by Arlene Ford March 1991 Download File  (pdf format) Education Series 2 Drug Policy in the Age of AIDS: The Philosophy of Harm Reduction by Rod Sorge April 1991 Download File (pdf format) Education Series 3 Myths About Methadone by Emmet Velten, Ph.D. March 1992 Download File (pdf…

Commentary on the NIH Consensus Development Statement(1) from the Meeting on November 17-19, 1997 Effective Medical Treatment of Heroin Addiction

ByAdmin
Admin 02/26/2023

The National Alliance of Methadone Advocates supports the NIH Consensus Statement on Effective Treatment of Heroin Addiction that was facilitated by the National Institute on Drug Abuse and the National Institute of Health. The imprecate of this special statement should be understood in order to realize the impact that it can have on methadone maintenance…

DOJ publishes guidance on Opioid Use Disorder and the Americans with Disabilities Act

ByAdmin
Admin 06/09/2022

DOJ publishes guidance on Opioid Use Disorder and the Americans with Disabilities Act NAMA Recovery    Patient Rights    April 15, 2022  |  0 “The opioid crisis poses an extraordinary challenge to communities throughout our country. The Department of Justice (the Department) has responded with a comprehensive approach prioritizing prevention, enforcement, and treatment. This includes…

The National Methadone Conference-1

ByAdmin
Admin 11/09/2022

American Association for the Treatment of Opioid Dependence Washington, D.C. ~ April 13-16, 2003 Session: Organizational Meeting April 15, 2003 Picture Essay of NAMA’s Organizational Meeting Starting the Meeting Joyce calls the meeting to order. Top (l-r) Robert Sanders (NYC NAMA), Becki Ballard (OK NAMA), Gary Nessenbaum (WAMM), Jennifer Nelson Connelly (PA NAMA), Joycelyn Woods,…

Federal Regulations & Documents

ByAdmin
Admin 01/26/2023

Code of Federal Regulations 42 CFR Part 8. Opioid Drugs in Maintenance and Detoxification Treatment of Opiate Addiction. Download PDF 42 CFR Part 2. Confidentiality of Alcohol and Drug Abuse Patient Records. Download PDF Federal Register 17 January 2001, Vol. 66, No. 11, pages 4076-4102.(PDF Format) Publication of Final Rule 42 CFR Part 2. Comments and…